144 related articles for article (PubMed ID: 3241329)
21. [A clinical study on S6472, sustained release preparation of cefaclor, dermatological area].
Kawanami T; Shibata A; Hanawa S; Morishima T
Jpn J Antibiot; 1990 Sep; 43(9):1621-8. PubMed ID: 2262967
[TBL] [Abstract][Full Text] [Related]
22. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
[TBL] [Abstract][Full Text] [Related]
23. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
24. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
[TBL] [Abstract][Full Text] [Related]
25. [Comparative clinical study of CS-807 and cefaclor in chronic respiratory tract infections by a double-blind method].
Shiba K; Saito A; Shimada J; Miyahara T; Onodera S; Sasaki N; Saito A; Tomizawa M; Nakayama I; Tamura M
Kansenshogaku Zasshi; 1988 Dec; 62(12):1166-91. PubMed ID: 3148015
[No Abstract] [Full Text] [Related]
26. [Clinical results of cefaclor treatment of infections of oral regions].
Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
[TBL] [Abstract][Full Text] [Related]
27. [Results of treatment with cefaclor, a new oral cephalosporin].
Fortschr Med; 1979 Oct; 97(38):1709-10. PubMed ID: 511065
[No Abstract] [Full Text] [Related]
28. A double-blind study comparing cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice.
Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rahman MK; Vallé-Jones JC
Pharmatherapeutica; 1980; 2(7):494-8. PubMed ID: 7010383
[TBL] [Abstract][Full Text] [Related]
29. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
[TBL] [Abstract][Full Text] [Related]
30. [Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
Kobayashi H; Kawai S; Saito A; Yajima O; Tomizawa M; Nakayama I; Ishikawa K; Tamura M; Ito T; Takeuchi K
Kansenshogaku Zasshi; 1986 Sep; 60(9):1052-77. PubMed ID: 3100702
[No Abstract] [Full Text] [Related]
31. Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
Dorow P
J Chemother; 1989 Aug; 1(4):257-60. PubMed ID: 2809693
[TBL] [Abstract][Full Text] [Related]
32. Therapy with cefaclor: analysis of infections in 189 French patients.
Masbernard A; Salord JC
Postgrad Med J; 1979; 55 Suppl 4():72-6. PubMed ID: 398484
[No Abstract] [Full Text] [Related]
33. [Cefaclor in the treatment of respiratory tract infections in children].
Klech H; Stur O; Götz M
Padiatr Padol; 1985; 20(3):297-306. PubMed ID: 4034220
[TBL] [Abstract][Full Text] [Related]
34. Cefaclor in the treatment of lower respiratory tract infections: a review.
Brown RB
Clin Ther; 1988; 11 Suppl A():54-65. PubMed ID: 3072087
[No Abstract] [Full Text] [Related]
35. [Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
Hara K; Saito A; Izumikawa K; Yamaguchi K; Suzuyama Y; Shigeno Y; Watanabe K; Komori M; Yamashita K; Miyazaki Y
Kansenshogaku Zasshi; 1984 Oct; 58(10):1046-72. PubMed ID: 6442319
[No Abstract] [Full Text] [Related]
36. [A clinical study on panipenem/betamipron in chronic respiratory tract infections].
Odagiri S; Matsumura M; Suzuki K; Murohashi K; Takahashi K; Ashikari Y; Yoshioka T; Matsumoto F; Imai T; Takeguchi K
Jpn J Antibiot; 1992 Feb; 45(2):160-71. PubMed ID: 1613969
[TBL] [Abstract][Full Text] [Related]
37. [Use of cefaclor monohydrate in infections of the upper and lower respiratory tract].
Abbatangelo R; Mascelloni R; Cavani E; Prete C
Clin Ter; 1988 Aug; 126(4):261-5. PubMed ID: 2974395
[No Abstract] [Full Text] [Related]
38. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
[TBL] [Abstract][Full Text] [Related]
39. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
[TBL] [Abstract][Full Text] [Related]
40. Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
Oberlin JA; Hyslop DL
Pediatr Infect Dis J; 1990 Jan; 9(1):41-4. PubMed ID: 2105479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
